Membrane localization is not required for Mpl function in normal hematopoietic cells

Blood

Volumn 98, Issue 7, 2001, Pages 2077-2083

  Otto, Kevin G ^a,b   Broudy, Virginia C ^a,b   Lin, Nancy L ^a,b   Parganas, Evan ^a,b   Luthi, Jennifer N ^a,b   Drachman, Jonathan G ^a,b   Ihle, James N ^a,b   Anthony Blau, C ^a,b,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; LIGAND; RETROVIRUS VECTOR; TACROLIMUS; THROMBOPOIETIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL MEMBRANE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DIMERIZATION; ERYTHROID CELL; FEMALE; FETUS LIVER; GENE ACTIVATION; GENE SEQUENCE; GENETIC CODE; HEMATOPOIETIC CELL; IN VITRO STUDY; KNOCKOUT MOUSE; LIVER CELL; MEGAKARYOCYTE; MOUSE; MYRISTYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; STEM CELL;

EID: 0035496945     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.7.2077     Document Type: Article

References (50)

1. Heldin CH. Dimerization of cell surface receptors in signal transduction. Cell. 1998;80:213-223.
2. Jacobson K, Sheets ED, Simson R. Revisiting the fluid mosaic model of membranes. Science. 1995;268:1441-1442.
3. Kurzchalia TV, Parton RG. Membrane microdomains and caveolae. Curr Opin Cell Biol. 1999;11:424-431.
4. Smart EJ, Graf GA, McNiven MA, et al. Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol. 1999;19:7289-7304.
5. Brown DA, London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem. 2000;275:17221-17224.
6. Remy I, Wilson IA, Michnick SW. Erythropoietin receptor activation by a ligand-induced conformational change. Science. 1999;283:990-993.
7. Livnah O, Stura EA, Middleton SA, Johnson DL, Jolliffe LK, Wilson IA. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science. 1999;283:987-990.
8. Wu H, Klingmuller U, Besmer P, Lodish HF. Interaction of the erythropoietin and stem-cell-factor receptors. Nature. 1995;377:242-246.
9. Jubinsky PT, Krijanovski OI, Nathan DG, Tavernier J, Sieff CA. The β chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor. Blood. 1997;90:1867-1873.
10. Ooi J, Tojo A, Asano S, Sato Y, Oka Y. Thrombopoietin induces tyrosine phosphorylation of a common β subunit of the GM-CSF receptor and its association with Stat5 in TF-1/Tpo cells. Biochem Biophys Res Comm. 1998;246:132-136.
11. Ceresa BP, Schmid SL. Regulation of signal transduction by endocytosis. Curr Opin Cell Biol. 2000;12:204-210.
12. Vieira AV, Lamaze C, Schmid SL. Control of EGF receptor signaling by clathrin-mediated endocytosis. Science. 1996;274:2086-2089.
13. Ceresa BP, Kao AW, Santeler SR, Pessin JE. Inhibition of clathrin-medicated endocytosis selectively attenuates specific insulin receptor signal-transduction pathways. Mol Cell Biol. 1998;18:3862-3870.
14. Fallon EM, Liparoto SF, Lee KJ, Ciardelli TL, Lauffenburger DA. Increased endosomal sorting of ligand to recycling enhances potency of an interleukin-2 analog. J Biol Chem 2000;275:6790-6797.
15. Clackson T, Yang W, Rozamus LW, et al. Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity. Proc Natl Acad Sci U S A. 1998;95:10437-10442.
16. Jin L, Zeng H, Chien S, et al. In vivo selection using a cell-growth switch. Nat Genet. 2000;26:64-66.
17. Richard RE, Wood S, Zeng H, Papayannopoulou T, Blau CA. Expansion of genetically modified primary human hemopoietic cells using chemical inducers of dimerization. Blood. 2000;95:430-436.
18. Pawson T, Scott JD. Signaling through scaffold, anchoring, and adaptor proteins. Science. 1997;278:2075-2080.
19. src-myristylation and membrane association and for cell transformation. Mol Cell Biol. 1984;4:1834-1842.
20. Hawley RG, Lieu FHL, Fong AZC, Hawley TS, Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1994;1:136-138.
21. Blau CA, Peterson KR, Drachman JG, Spencer DM. A proliferation switch for genetically modified cells. Proc Natl Acad Sci U S A. 1997;94:3076-3081.
22. Jin L, Asano H, Blau CA. Stimulating cell proliferation through the pharmacologic activation of c-kit. Blood. 1998;91:890-897.
23. Drachman JG, Millet KM, Kaushansky K. Thrombopoietin signal transduction requires functional JAK2, not TYK2. J Biol Chem. 1999;274:13480-13484.
24. Broudy VC, Lin NL, Priestley GV, Nocka K, Wolf NS. Interaction of stem cell factor and its receptor c-kit mediates lodgment and acute expansion of hematopoietic cells in the murine spleen. Blood. 1996;88:75-81.
25. Broudy VC, Lin NL, Fox N, Taga T, Saito M, Kaushansky K. Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit. Blood. 1996;88:2026-2032.
26. Broudy VC, Tait J, Powell JS. Recombinant human erythropoietin: purification and analysis of carbohydrate linkage. Arch Biochem Biophys. 1988;265:329-336.
27. Parganas E, Wang D, Stravopodis D, et al. JAK2 is essential for signaling through a variety of cytokine receptors. Cell. 1998;93:385-395.
28. Teglund S, McKay C, Schuetz E, et al. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell. 1998;93:841-850.
29. Broudy VC, Lin NL, Bühring H-J, Komatsu N, Kavanagh TJ. Analysis of c-kit receptor dimerization by fluorescence resonance energy transfer. Blood. 1998;91:898-906.
30. Koury MJ, Bondurant MC, Rana SS. Changes in erythroid membrane proteins during erythropoietin-mediated terminal differentiation. J Cell Phys. 1987;133:438-448.
31. Cullen BR. Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol. 1987;152:684-704.
32. Sabath DF, Lin N, Sabath DE, Kaushansky K, Broudy VC. Tyrosine 462 of the membrane-proximal F′-G′ loop of murine Mpl is not essential for high-affinity binding of thrombopoietin. Cytokine. 2000;12:127-130.
33. Sato T, Fuse A, Niimi H, Fielder PJ, Avraham H. Binding and regulation of thrombopoietin to human megakaryocytes. Br J Haematol. 1998;100:704-711.
34. Broudy VC, Lin NL, Sabath DF, Papayannopoulou T, Kaushansky K. Human platelets display high-affinity receptors for thrombopoietin. Blood. 1997;89:1896-1904.
35. Fielder PJ, Hass P, Nagel M, et al. Human platelets as a model for the binding and degradation of thrombopoietin. Blood. 1997;89:2782-2788.
36. Scott CL, Robb L, Papaevangeliou B, Mansfield R, Nicola NA, Begley CG. Reassessment of interactions between hematopoietic receptors using common β-chain and interleukin-3-specific receptor β-chain-null cells: no evidence of functional interactions with receptors for erythropoietin, granulocyte colony-stimulating factor, or stem cell factor. Blood. 2000;96:1588-1590.
37. Jiang G, Hunter T. Receptor signaling: when dimerization is not enough. Curr Biol. 1999;9:R568-R571.
38. Fielder PJ, Gurney AL, Stefanich E, et al. Regulation of thrombopoietin levels by c-Mpl-mediated binding to platelets. Blood. 1996;87:2154-2161.
39. Dahlen DD, Broudy VC, Drachman JG. Internalization of the thrombopoietin receptor Mpl in response to ligand binding: the role of dileucine motifs [abstract]. Blood. 1999;94:265.
40. Waterman H, Sabanai I, Geiger B, Yarden Y. Alternative intracellular routing of ErbB receptors may determine signaling potency. J Biol Chem. 1998;22:13819-13827.
41. Spencer DM, Wandless TJ, Schreiber SL, Crabtree GR. Controlling signal transduction with synthetic ligands. Science. 1993;262:1019-1024.
42. Belshaw PJ, Ho SN, Crabtree GR, Schreiber SL. Controlling protein association and subcellular localization with a synthetic ligand that induces heterodimerization of proteins. Proc Natl Acad Sci U S A. 1996;93:4604-4607.
43. Yang JX, Symes K, Mercola M, Schreiber SL. Small-molecule control of insulin and PDGF receptor signaling and the role of membrane attachment. Curr Biol. 1997;8:11-18.
44. Pawson T. Protein modules and signalling networks. Nature. 1995;373:573-580.
45. Wiley HS, Woolf MF, Opresko LK, et al. Removal of the membrane-anchoring domain of epidermal growth factor leads to intracrine signaling and disruption of mammary epithelial cell organization. J Cell Biol. 1998;143:1317-1328.
46. Dunbar CE, Browder TM, Abrams JS, Neinhuis AW. COOH-terminal-modified interleukin-3 is retained intracellularly and stimulates autocrine growth. Science. 1989;245:1493-1496.
47. Neubauer H, Cumano A, Müller M, Wu H, Huffstadt U, Pfeffer K. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell. 1998;93:397-409.
48. Schwaller J, Frantsve J, Aster J, et al. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2fusion genes. EMBO J. 1998;18:5321-5333.
49. Jin L, Siritanaratkul N, Emery W, et al. Targeted expansion of genetically modified bone marrow cells. Proc Natl Acad Sci U S A. 1998;95:8093-8097.
50. Zeng H, Masuko M, Jin L, Neff T, Otto KG, Blau CA. Receptor specificity in the self-renewal and differentiation of primary multipotential hemopoietic cells. Blood. 2001;98:328-334.